SCHEMBL21167601

SCHEMBL21167601

Nc1ncc(-c2cn[nH]c2)nc1NCc1ccn2nccc2n1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CSF1R P07333 1/20 0.40
LDHA P00338 1/20 0.37
LDHB P07195 1/20 0.37
MET P08581 3/20 0.36
DYRK1A Q13627 1/20 0.36
KCNA5 P22460 1/20 0.35
MAPK1 P28482 3/20 0.35
PIK3CD O00329 1/20 0.34
PIK3R1 P27986 1/20 0.34
PIK3CA P42336 1/20 0.34
PIK3CB P42338 1/20 0.34
PIK3CG P48736 1/20 0.34
CCNK O75909 1/20 0.33
CDK12 Q9NYV4 1/20 0.33
MKNK1 Q9BUB5 1/20 0.32
MKNK2 Q9HBH9 1/20 0.32
PIM1 P11309 1/20 0.32
PIM2 Q9P1W9 1/20 0.32
AKT1 P31749 2/20 0.32
AKT2 P31751 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21167751 0.82 LDHA (0.43) CSF1RLDHALDHBMETMAPK1
SCHEMBL21167604 0.82 CSF1R (0.62) CSF1RLDHALDHBMETMAPK1
SCHEMBL21167444 0.79 CSF1R (0.46) CSF1RLDHALDHBMETIKBKE
SCHEMBL24590999 0.78 MET (0.44) CSF1RLDHALDHBMETDYRK1A
SCHEMBL22475816 0.72 CSF1R (0.31) CSF1RMET
SCHEMBL21167443 0.69 MET (0.42) CSF1RMETMAPK1
SCHEMBL22475684 0.67
SCHEMBL21167328 0.67 MAPK1 (0.36) CSF1RLDHALDHBMAPK1IKBKE
SCHEMBL24591017 0.67 MET (0.43) CSF1RMET
SCHEMBL21167667 0.65 LDHA (0.44) CSF1RLDHALDHBMETMKNK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3511330-B1 SYNTHETIC INTERMEDIATE USEFUL IN THE PREPARATION OF TRIAZOLOPYRIDINE C-MET INHIBITORS HUTCHISON MEDIPHARMA LTD (CN) 2020-09-30 EP disclosed
EP-3511330-A1 SYNTHETIC INTERMEDIATE USEFUL IN THE PREPARATION OF TRIAZOLOPYRIDINE C-MET INHIBITORS Hutchison Medipharma Limited (CN) 2019-07-17 EP disclosed